ALQA - Alliqua BioMedical, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue2,2162,01916,29412,177
Cost of Revenue1,7201,8418,1445,227
Gross Profit4961788,1506,950
Operating Expenses
Research Development--859715
Selling General and Administrative5,7925,30335,32534,340
Non Recurring----
Others----
Total Operating Expenses7,5127,14444,32840,282
Operating Income or Loss-5,296-5,125-28,034-28,105
Income from Continuing Operations
Total Other Income/Expenses Net-1,708881-5,720-830
Earnings Before Interest and Taxes-5,296-5,125-28,034-28,105
Interest Expense---2,541-1,565
Income Before Tax-7,004-4,244-33,754-28,935
Income Tax Expense---715-1,718
Minority Interest----
Net Income From Continuing Ops-7,004-4,244-33,039-27,217
Non-recurring Events
Discontinued Operations-1,413-21,4634,7961,200
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-8,417-25,707-28,243-26,017
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-8,417-25,707-28,243-26,017